PPARgamma modulates vascular smooth muscle cell phenotype via a protein kinase G-dependent pathway and reduces neointimal hyperplasia after vascular injury

Han-Mo YANG; Baek-Kyung KIM; Ju-Young KIM; Yoo-Wook KWON; Sooryeonhwa JIN; Joo-Eun LEE; Hyun-Jai CHO; Hae-Young LEE; Hyun-Jae KANG; Byung-Hee OH; Young-Bae PARK; Hyo-Soo KIM.
Experimental & Molecular Medicine ; : e65-2013.
Artículo en Inglés | WPRIM | ID: wpr-152459

Documentos relacionados

  1. PPARγ modulates vascular smooth muscle cell phenotype via a protein kinase G-dependent pathway and reduces neointimal hyperplasia after vascular injury.
  2. Targeting the Alternative Vitamin E Metabolite Binding Site Enables Noncanonical PPARγ Modulation.
  3. The PPAR-γ agonist pioglitazone exerts proinflammatory effects in bronchial epithelial cells during acute Pseudomonas aeruginosa pneumonia.
  4. PPARγ alleviates peritoneal fibrosis progression along with promoting GLUT1 expression and suppressing peritoneal mesothelial cell proliferation.
  5. Quantitative structural assessment of graded receptor agonism.
  6. Brown Adipose Tissue PPARγ Is Required for the Insulin-Sensitizing Action of Thiazolidinediones.
  7. Peroxisome Proliferator-Activated Receptor-γ Agonist Attenuates Vocal Fold Fibrosis in Rats via Regulation of Macrophage Activation.
  8. Structure-activity relationships of rosiglitazone for peroxisome proliferator-activated receptor gamma transrepression.
  9. PPARγ agonist inhibits c-Myc-mediated colorectal cancer tumor immune escape.
  10. Isoform-specific functions of PPARγ in gene regulation and metabolism.